IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer

被引:21
|
作者
Westeel, V.
Lebitasy, M. P.
Mercier, M.
Girard, P.
Barlesi, F.
Blanchon, F.
Tredaniel, J.
Bonnette, P.
Woronoff-Lemsi, M. C.
Breton, J. L.
Azarian, R.
Falcoz, P. E.
Friard, S.
Geriniere, L.
Laporte, S.
Lemarie, E.
Quoix, E.
Zalcman, G.
Guigay, J.
Morin, F.
Milleron, B.
Depierre, A.
机构
[1] Univ Franche Comte, CHU Besancon, Serv Pneumol, F-25030 Besancon, France
[2] IFCT, Paris, France
[3] Univ Franche Comte, Serv Biomath, F-25030 Besancon, France
[4] Ctr Mutualiste Montsouris, Paris, France
[5] APHM, Marseille, France
[6] APHP Hop St Louis, Paris, France
[7] Ctr Hosp Foch, Suresnes, France
[8] CH Versailles, Versailles, France
[9] Hop Foch, Suresnes, France
[10] Ctr Hosp Lyon Sud, HCL, F-69310 Pierre Benite, France
[11] CHU Tours, Tours, France
[12] CHU Strasbourg, F-67000 Strasbourg, France
[13] CHU Caen, F-14000 Caen, France
[14] Inst Gustave Roussy, Villejuif, France
[15] APHP Hop Tenon, Paris, France
关键词
lung cancer; post-operative follow-up; randomised trial; surgery; non-small cell lung cancer;
D O I
10.1016/S0761-8425(07)91135-3
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background The authorities advocate a minimalist attitude towards the follow-up of resected bronchial carcinoma (clinical examination and chest x-ray). A survey showed that 70% of French respiratory physicians have chosen to use the CT scanner and often endoscopy. The published data are equivocal and are often based on retrospective studies. Lung cancer is a good model for a study of post-operative surveillance. Recurrences often occur in easily observed areas, they may be detected while still asymptomatic and are sometimes potentially curable. Second primary tumours may develop at the same site. Methods The Intergroupe Francophone de Cancerologie Thoracique (IFCT) has initiated a trial comparing simple follow-up (clinical examination, chest x-ray) with a more intensive followup (CT scan, fibreoptic bronchoscopy). The surveillance will take place every 6 months for 2 years and then annually until 5 years. Expected results The main aim is to determine whether intensive follow-up improves patient survival. The opposite question is equally important. If an expensive and demanding follow-up does not affect the chances of cure these results will influence our practice.
引用
收藏
页码:645 / 652
页数:8
相关论文
共 50 条
  • [31] Follow-up in non-small-cell lung cancer
    Rothschild S.I.
    Lardinois D.
    Bremerich J.
    Tamm M.
    Bubendorf L.
    Papachristofilou A.
    Stoll H.
    Zippelius A.
    memo - Magazine of European Medical Oncology, 2014, 7 (2) : 97 - 101
  • [32] Efficacy of adjuvant chemotherapy for completely resected stage IB non-small cell lung cancer: a retrospective study
    Park, Hye Jung
    Park, Heae Surng
    Cha, Yoon Jin
    Lee, Sungsoo
    Jeung, Hei-Cheul
    Cho, Jae Yong
    Kim, Hyung Jung
    Byun, Min Kwang
    JOURNAL OF THORACIC DISEASE, 2018, 10 (04) : 2279 - 2287
  • [33] Referral patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer
    Kassam, Farrah
    Shepherd, Frances A.
    Johnston, Michael
    Visbal, Antonio
    Feld, Ronald
    Darling, Gail
    Keshavjee, Shaf
    Pierre, Andrew
    Waddell, Thomas
    Leighl, Natasha B.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (01) : 39 - 43
  • [34] Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer
    Shuji Murakami
    Haruhiro Saito
    Tetsuro Kondo
    Hiroyuki Ito
    Fumihiro Oshita
    Kouzo Yamada
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 81 - 87
  • [35] Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer
    Murakami, Shuji
    Saito, Haruhiro
    Kondo, Tetsuro
    Ito, Hiroyuki
    Oshita, Fumihiro
    Yamada, Kouzo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (01) : 81 - 87
  • [36] The Significance of the Prognostic Nutritional Index in Patients with Completely Resected Non-Small Cell Lung Cancer
    Mori, Shunsuke
    Usami, Noriyasu
    Fukumoto, Koichi
    Mizuno, Tetsuya
    Kuroda, Hiroaki
    Sakakura, Noriaki
    Yokoi, Kohei
    Sakao, Yukinori
    PLOS ONE, 2015, 10 (09):
  • [37] Adjuvant Chemotherapy is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer
    Nakata, M.
    Nojima, Y.
    Nanba, K.
    Saisho, S.
    Shimizu, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S845 - S846
  • [38] Isolated brain metastasis as a late recurrence of completely resected non-small cell lung cancer
    Ju, Lixia
    Han, Mingquan
    ONCOLOGY LETTERS, 2016, 12 (01) : 731 - 733
  • [39] Impact of adjuvant chemotherapy in completely resected stage IIIA non-small cell lung cancer
    Naim Younes, R.
    Gross, J. L.
    Abrao, F. C.
    Rodrigues Pereira, J.
    MINERVA CHIRURGICA, 2013, 68 (02) : 169 - 174
  • [40] Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC)
    Liang, Ying
    Wakelee, Heather A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (05) : 403 - 410